What Is Falmina? Birth Control Uses & Side Effects

Falmina is a combination birth control pill containing two synthetic hormones: levonorgestrel (a progestin) and ethinyl estradiol (an estrogen). Each pack includes 21 active orange tablets and 7 inactive tablets, taken daily on a 28-day cycle. It’s a low-dose formulation, with 0.10 mg of levonorgestrel and 0.02 mg of ethinyl estradiol per active pill.

Falmina is a generic oral contraceptive, meaning it’s typically less expensive than brand-name equivalents that use the same hormone combination. It’s available by prescription only.

How Falmina Prevents Pregnancy

Falmina works primarily by stopping an egg from fully developing each month. Without a mature egg, fertilization can’t happen. The hormones also thicken cervical mucus, making it harder for sperm to reach the uterus, and thin the uterine lining, which reduces the likelihood of implantation.

With perfect use (taking the pill at the same time every day, no missed doses), the failure rate is about 0.3% per year. In typical use, which accounts for the reality of occasionally missing pills or taking them late, that number rises to about 9% per year. The gap between those two numbers highlights how much consistency matters with this type of contraceptive.

How to Take It

You take one orange active tablet daily for 21 days, followed by 7 inactive (placebo) tablets. Your period typically arrives during the placebo week. After finishing the pack, you start a new one the next day regardless of whether your period has ended.

Timing matters. Taking the pill at roughly the same time each day keeps hormone levels steady and maximizes effectiveness. If you experience vomiting or diarrhea, hormone absorption can decrease, which may reduce protection temporarily. Using a backup method like condoms for the rest of that cycle is a reasonable precaution in those situations.

Common Side Effects

Falmina shares the side effect profile of other combined oral contraceptives. Some degree of fluid retention is common, which can show up as mild bloating or breast tenderness. Nausea, headaches, and spotting between periods are also frequently reported, especially in the first few months as your body adjusts.

Mood changes are possible. Women with a history of depression should pay attention to any worsening symptoms, as the hormones can sometimes trigger a recurrence. Contact lens wearers occasionally notice changes in lens comfort or vision, which is related to how hormonal shifts affect fluid balance in the eyes.

Serious Risks

Like all combined hormonal contraceptives, Falmina carries a small but real risk of blood clots. The estimated rate is 3 to 9 cases per 10,000 women per year of use. These clots can form in the deep veins of the legs (deep vein thrombosis) or travel to the lungs (pulmonary embolism). Heart attack and stroke are also possible, though rare in healthy women without other risk factors.

Smoking dramatically increases these cardiovascular risks, especially for women over 35. The combination of cigarette use, age, and hormonal contraception is dangerous enough that Falmina is specifically not recommended for women over 35 who smoke.

Some research has found a small increase in breast cancer risk among current or recent users, and a possible link to cervical cancer with long-term use. Benign liver tumors have also been associated with oral contraceptive use, though they’re rare. These risks are worth knowing about, but for most healthy, non-smoking women, the overall risk of serious complications remains low.

Who Should Not Take Falmina

Falmina is not appropriate for everyone. The list of conditions that rule it out includes:

  • Blood clot history or clotting disorders: current or past deep vein thrombosis, pulmonary embolism, or inherited clotting conditions
  • Heart or blood vessel disease: coronary artery disease, stroke history, or heart valve problems that increase clot risk
  • Migraines with aura: this specific type of migraine is associated with higher stroke risk on combined hormonal birth control
  • Uncontrolled high blood pressure
  • Diabetes with vascular complications
  • Breast cancer: known, suspected, or a personal history
  • Active liver disease or liver tumors
  • Unexplained vaginal bleeding
  • Certain hepatitis C medications: specific antiviral drug combinations can cause dangerous liver enzyme elevations when taken with hormonal contraceptives
  • Smokers over age 35

Women over 35 who have migraines of any kind are also advised against using combined pills like Falmina, even without aura. Prolonged immobilization, such as recovery from major surgery, is another situation where the clot risk makes this pill a poor choice.

Falmina Compared to Other Pills

Falmina uses the same hormone combination and doses found in several other oral contraceptives. It belongs to a class of low-dose pills, with its ethinyl estradiol content (0.02 mg) sitting at the lower end of what’s available. Lower estrogen doses generally mean fewer estrogen-related side effects like bloating and nausea, though breakthrough bleeding can be slightly more common compared to higher-dose formulations.

Because Falmina is a monophasic pill, every active tablet contains the same amount of hormone. This is simpler than triphasic pills, where the hormone dose changes across the cycle. If you miss a pill and need to double up, monophasic pills make that process more straightforward since all active tablets are identical.